glp 1 injection alternative FDA approves Foundayo, an oral GLP-1 to Wegovy and Ozempic Compound versions of GLP-1 drugs
Description
This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

Moreover, it remains to be shown that GIPR agonism can improve insulin secretion in type 2 diabetic patients who have been noted in previous studies to be unresponsive to GIP

These assets aim to move beyond the current weekly injection paradigm, signalling a future where extended dosing intervals could become central to maintenance strategies [16].

Well, thats exactly what happened with the GLP-1 receptor agonists

Reduced risk of side effects

Studies found that the semaglutide pill works about as well for weight loss as the injectable version of semaglutide
